Cote G - Search Results

1

Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase.

Gao Y, Fotovati A, Lee C, Wang M, Cote G, Guns E, Toyota B, Faury D, Jabado N, Dunn SE. Gao Y, et al. Among authors: cote g. Mol Cancer Ther. 2009 Dec;8(12):3276-84. doi: 10.1158/1535-7163.MCT-09-0478. Mol Cancer Ther. 2009. PMID: 19996271

2

Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors.

Jin W, McCutcheon IE, Fuller GN, Huang ES, Cote GJ. Jin W, et al. Among authors: cote gj. Cancer Res. 2000 Mar 1;60(5):1221-4. Cancer Res. 2000. PMID: 10728679

3

Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers.

Adashek JJ, Desai AP, Andreev-Drakhlin AY, Roszik J, Cote GJ, Subbiah V. Adashek JJ, et al. Mol Cancer Ther. 2021 Oct;20(10):1769-1776. doi: 10.1158/1535-7163.MCT-21-0329. Epub 2021 Sep 6. Mol Cancer Ther. 2021. PMID: 34493590 Free PMC article. Review.

4

PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis.

Izaguirre DI, Zhu W, Hai T, Cheung HC, Krahe R, Cote GJ. Izaguirre DI, et al. Mol Carcinog. 2012 Nov;51(11):895-906. doi: 10.1002/mc.20859. Epub 2011 Oct 4. Mol Carcinog. 2012. PMID: 21976412 Free PMC article.

5

Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.

Phan LM, Fuentes-Mattei E, Wu W, Velazquez-Torres G, Sircar K, Wood CG, Hai T, Jimenez C, Cote GJ, Ozsari L, Hofmann MC, Zheng S, Verhaak R, Pagliaro L, Cortez MA, Lee MH, Yeung SC, Habra MA. Phan LM, et al. Among authors: cote gj. Cancer Res. 2015 Oct 1;75(19):4131-42. doi: 10.1158/0008-5472.CAN-14-3707. Epub 2015 Aug 17. Cancer Res. 2015. PMID: 26282167 Free PMC article.

6

Polypyrimidine tract-binding protein down-regulates fibroblast growth factor receptor 1 alpha-exon inclusion.

Jin W, Bruno IG, Xie TX, Sanger LJ, Cote GJ. Jin W, et al. Among authors: cote gj. Cancer Res. 2003 Oct 1;63(19):6154-7. Cancer Res. 2003. PMID: 14559795

7

Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain.

McCutcheon IE, Hentschel SJ, Fuller GN, Jin W, Cote GJ. McCutcheon IE, et al. Neuro Oncol. 2004 Jan;6(1):9-14. doi: 10.1215/S1152851703000279. Neuro Oncol. 2004. PMID: 14769134 Free PMC article.

8

Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma.

Cheung HC, Corley LJ, Fuller GN, McCutcheon IE, Cote GJ. Cheung HC, et al. Mod Pathol. 2006 Aug;19(8):1034-41. doi: 10.1038/modpathol.3800635. Epub 2006 May 26. Mod Pathol. 2006. PMID: 16729017 Free article.

9

Sequence requirements for regulated RNA splicing of the human fibroblast growth factor receptor-1 alpha exon.

Cote GJ, Huang ES, Jin W, Morrison RS. Cote GJ, et al. J Biol Chem. 1997 Jan 10;272(2):1054-60. doi: 10.1074/jbc.272.2.1054. J Biol Chem. 1997. PMID: 8995402 Free article.

10

Exon sequence is required for regulated RNA splicing of the human fibroblast growth factor receptor-1 alpha-exon.

Jin W, Huang ES, Bi W, Cote GJ. Jin W, et al. Among authors: cote gj. J Biol Chem. 1998 Jun 26;273(26):16170-6. doi: 10.1074/jbc.273.26.16170. J Biol Chem. 1998. PMID: 9632672 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,021 results

Search Page

Filters